(Q34059381)

English

Nateglinide

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

Nateglinide. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Dunn CJ

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Faulds D

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

1 September 2000

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

60

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

607-615; discussion 616-7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

A novel D-phenylalanine-derivative hypoglycemic agent A-4166 increases cytosolic free Ca2+ in rat pancreatic beta-cells by stimulating Ca2+ influx

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of insulin and somatostatin release by two meglitinide analogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of a new hypoglycemic agent, A-4166 [(-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine], on postprandial blood glucose excursion: comparison with voglibose and glibenclamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on the N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanin e (A-4166)receptor in HIT T-15 cells. Displacement of [3H]glibenclamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of food on the oral bioavailability and the pharmacodynamic actions of the insulinotropic agent nateglinide in healthy subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ay-4166 increases the sensitivity of insulin secretion to glucose in isolated perfused rat pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure determination of metabolites isolated from urine and bile after administration of AY4166, a novel D-phenylalanine-derivative hypoglycemic agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166) on insulin and glucagon secretion in isolated perfused rat pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-4166, in perfused rat pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-dose pharmacokinetics of nateglinide in subjects with hepatic cirrhosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulinotropic action of meglitinide analogues: modulation by an activator of ATP-sensitive K+ channels and high extracellular K+ concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoglycaemic agents, NN623 and A4166.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic beta-cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic effects of nateglinide and meal administration on insulin secretion in patients with type 2 diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166).

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide

1 reference

https://pubmed.ncbi.nlm.nih.gov/11030470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200060030-00007

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34059381&oldid=2196185442"